Advertisement

Topics

Oslo Børs Company Profile

03:50 EST 17th December 2018 | BioPortfolio

In the early 1800s, Norway was a country of farmers and fishermen. Christiania, as the capital city was then called, had just 10,000 inhabitants. The Norwegian economy was weak, and money was scarce. This had a crushing effect on business and industry, and it was decided that the country needed a commercial exchange to encourage greater commercial activity.The merchant Nicolay Andresen is generally recognised as the "father" of the Oslo stock exchange. He made the first proposal for a commercial exchange to the Norwegian parliament in 1818, and a small committee of four leading businessmen was established to progress the idea.

Location

PO.Box. 460
Sentrum
Oslo
N-0105
Norway

Contact

Phone: 47 22 34 17 00
Fax: 47 22 34 19 25
Email: ma@oslobors.no


News Articles [55 Associated News Articles listed on BioPortfolio]

Les habitants d'Oslo, capital de la Norvège, rendent hommage à l'écotourisme et à la ...

OSLO, Norvège, 19 septembre 2018 /PRNewswire/ -- Dans la matinée du 13 septembre (heure locale), les habitants d'Oslo, capitale de la Norvège, ont été touchés Read more...

How the Oslo Cancer Cluster is providing a Nordic hub in Oncology.

Ketil Widerberg, CEO to Oslo Cancer Cluster, discusses the concept behind of their recently-opened Innovation Park.

Medigene: Neues von den Oslo-Studien

Medigene hat am Montag Daten zu klinischen Untersuchungen von Wissenschaftlern des Oslo University Hospital mit dendritischen Zell-Impfstoffen gemeldet. Mit dem, Hospital besteht eine Zusammenarbei...

PTA-News: Medigene AG: Akademischer Partner Oslo University Hospital präsentierte klinische CU Daten mit AML DC-Vakzine bei ASH

Unternehmensmitteilung für den Kapitalmarkt Martinsried/München (pta009/03.12.2018/07:30) - Die Medigene AG gibt bekannt, dass Wissenschaftler des Oslo University Hospitals ein Update ihrer klinisc....

MediGene AG mit positiven Nachrichten aus Oslo - Aktie schließt Woche positiv ab

Die MediGene AG hat positive Nachrichten von einer Studie der Oslo University Hospital erhalten. Hierbei werden Zellimpfstoffe in einer Zusammenarbeit an Patienten getestet. Diese Zellimpfstoffe wu...

MediGene AG mit positiven Nachrichten aus Oslo - Aktie schließt Woche positiv ab!

Die MediGene AG hat positive Nachrichten von einer Studie der Oslo University Hospital erhalten. Hierbei werden Zellimpfstoffe in einer Zusammenarbeit an Patienten getestet. Diese Zellimpfstoffe wu...

Nordic Nanovector ASA: Allocation of Restricted Stock Unites (RSUs) to the Board of Directors

OSLO, Norway, June 8, 2018 /PRNewswire/ -- Reference is made to the minutes from Nordic Nanovector ASA's (the "Company") (OSE: NANO) annual general meeting held on 30 May 2018 in Oslo, Norway (the...

Accelerating the development of new cancer therapies; Ketil Widerberg, General Manager, Oslo Cancer Cluster

Four out of ten people will be diagnosed with cancer during their life and it is crucial to develop new diagnostics and medication. Oslo Cancer Cluster is an oncology research and industry cluster de...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Metvixia™ (methyl aminolevulinate) cream, 16.8%for topical use only. not for ophthalmic, oral, or intravaginal usemust be dispensed to and applied by a physician. [Penn Pharmaceutical Services Ltd.]

METVIXIA™ (methyl aminolevulinate) Cream, 16.8%For Topical Use Only. Not for Ophthalmic, Oral, or Intravaginal UseMust be dispensed to and applied by a physician.

PubMed Articles [164 Associated PubMed Articles listed on BioPortfolio]

The LASSO Program in Oslo: Harm Reduction Using Buprenorphine-Naloxone (Suboxone®) in a Low Threshold Setting.

This is a 6-year retrospective quality control study of the LASSO Program (Low Threshold Substitution Treatment in Oslo), using exclusively Suboxone® (buprenorphine-naloxone [BPNX]) in out-patient se...

Corrigendum.

Acknowledgements.

Highlights in this issue.

Highlights in this issue.

Clinical Trials [41 Associated Clinical Trials listed on BioPortfolio]

GHB Poisoning and Poisoning Induced by Others

Patients with suspected GHB poisoning presenting to Oslo Accident and Emergency Outpatient Clinic (Oslo Legevakt) or a hospital in Oslo (Oslo University Hospital Ullevål, Diakonhjemmet, L...

Prevalence of Sexually Transmitted Infections Among People Attending the Sexual Assault Center in Oslo, Norway.

In this study we seek to register the prevalence of sexually transmitted infections (STI) among people attending the Sexual Assault Centre in Oslo, Norway. The main aim of this study is to...

Mindfulness Training for Stress Management

This study will assess the short and long term effects of a group-based mindfulness programme (Mindfulness-Based Stress Reduction, MBSR) on first year medical and psychology students at th...

Long-term Cancer Risk in the Randomised Oslo Diet and Antismoking Study

This study examines the effect of a five-year multifactorial lifestyle intervention in the Oslo diet and antismoking study on long-term cancer risk. In 1972-1973, 1232 men with high cardio...

Lifestyle Intervention for Pakistani Women in Oslo

Immigrants from South Asia in Norway have a high prevalence of type 2 diabetes and conditions related to the metabolic syndrome. It has been documented that these conditions may be prevent...

Companies [44 Associated Companies listed on BioPortfolio]

The University of Oslo (UiO)

The University of Oslo is Norway’s largest and oldest institution of higher education. It was founded in 1811 when Norway was still under Danish rule. Today the University of Oslo has approx. 30,000...

Oslo Patentkontor AS

The origins of Oslo Patentkontor AS date back to 1911, and it is thereby one of the oldest patent agencies in Norway.An important cornerstone was laid down in 1927 when Alf B. Bryn left his father’s...

DiaGenic ASA

DiaGenic ASA benefits from strong shareholders, a qualified staff and Board of Directors representing a wide range of experience. The company currently has nine employees and is located at Helsfyr in ...

Oslo Cancer Cluster Innovation Park

The vision of the Oslo Cancer Cluster Innovation Park is to create Europe’s leading environment for education, research and industry within oncology, while also shortening th...

Farmasøytisk Institutt

The School of Pharmacy at the University of Oslo (UiO) was established in 1932 at the new university campus at Blindern, Oslo. Up until 1994 The School of Pharmacy was the only educational institution...

More Information about "Oslo Børs" on BioPortfolio

We have published hundreds of Oslo Børs news stories on BioPortfolio along with dozens of Oslo Børs Clinical Trials and PubMed Articles about Oslo Børs for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oslo Børs Companies in our database. You can also find out about relevant Oslo Børs Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record